Myriad Genetics
MYGN
#7206
Rank
โ‚น57.66 B
Marketcap
โ‚น602.87
Share price
-4.80%
Change (1 day)
-16.93%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2026 (TTM): -โ‚น33.41 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are โ‚น0.82 Billion. In 2025 the company made an earning of -โ‚น36.52 Billion a decrease over its 2024 earnings that were of -โ‚น11.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น33.41 Billion-8.51%
2025 -โ‚น36.52 Billion218.91%
2024 -โ‚น11.45 Billion-53.49%
2023 -โ‚น24.62 Billion88.72%
2022 -โ‚น13.05 Billion172.08%
2021 -โ‚น4.8 Billion
2019 -โ‚น2.5 Billion-175.14%
2018 โ‚น3.32 B-70.81%
2017 โ‚น11.38 B22.22%
2016 โ‚น9.31 B-38.8%
2015 โ‚น15.21 B-6.12%
2014 โ‚น16.21 B-41.07%
2013 โ‚น27.50 B46.67%
2012 โ‚น18.75 B15.84%
2011 โ‚น16.19 B17.6%
2010 โ‚น13.76 B-15.96%
2009 โ‚น16.38 B
2007 -โ‚น3.96 Billion40.96%
2006 -โ‚น2.81 Billion
2003 -โ‚น3.26 Billion34.8%
2002 -โ‚น2.42 Billion89.21%
2001 -โ‚น1.28 Billion3.93%
2000 -โ‚น1.23 Billion21.76%
1999 -โ‚น1.01 Billion-25.61%
1998 -โ‚น1.36 Billion38.83%
1997 -โ‚น0.98 Billion-24.26%
1996 -โ‚น1.3 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
โ‚น772.52 B-2,208.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-โ‚น17.31 Billion-52.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น14.15 B-138.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚น3.32 Billion-90.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
โ‚น33.26 B-190.78%๐Ÿ‡บ๐Ÿ‡ธ USA